AEterna Zentaris will disclose 2006 second quarter financial and operating results on August 11
August 03 2006 - 8:30AM
PR Newswire (US)
QUEBEC, Aug. 3 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc.
(TSX: AEZ; Nasdaq: AEZS) announced that its Second Quarter 2006
conference call and webcast have been scheduled for Friday, August
11, 2006, at 11:00 a.m. ET. The conference call will follow the
press release of AEterna Zentaris' 2006 second quarter financial
and operating results issued earlier on the same day. Participants
may access the live webcast via the Company's website at
http://www.aeternazentaris.com/ in the "investors" section, or by
telephone using the following number: 800-257-3401. A replay of the
webcast will also be available on the website for a period of 30
days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a
growing global biopharmaceutical company engaged in the discovery,
development and marketing of therapies for cancer and endocrine
disorders. AEterna Zentaris also owns 48.26% of the equity of
Atrium Biotechnologies Inc. (TSX: ATB) and 64.69% of its voting
rights. Atrium is a developer, manufacturer and marketer of
science-based products for the cosmetics, pharmaceutical, chemical
and nutritional industries. News releases and additional
information are available at http://www.aeternazentaris.com/.
DATASOURCE: AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES
LABORATOIRES AETERNA LABORATORIES INC.) CONTACT: Media Relations:
Paul Burroughs, (418) 652-8525 ext. 406, ; Investor Relations:
Jenene Thomas, (418) 655-6420 or (908) 996-3154,
Copyright